<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Institutional investors in Edwards Lifesciences Corporation (NYSE:EW) see US$1.5b decrease in market cap last week, although long-term gains have benefitted them. — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Institutional investors in Edwards Lifesciences Corporation (NYSE:EW) see US$1.5b decrease in market cap last week, although long-term gains have benefitted them.</h2>
    <div class="badge">2025-09-15T12:30:30+00:00</div>
    <ul>
      <li>Though their holding amounts to less than 1%, we can see that board members collectively own US$418m worth of shares (at current prices).</li>
<li>is currently the largest shareholder, with 12% of shares outstanding.</li>
<li>Still, the 12% one-year gains may have helped mitigate their overall losses.</li>
<li>And the group that holds the biggest piece of the pie are institutions with 88% ownership.</li>
<li>In comparison, the second and third largest shareholders hold about 9.5% and 4.4% of the stock.</li>
<li>Our data suggests that insiders own under 1% of Edwards Lifesciences Corporation in their own names.</li>
<li>Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Institutional investors in Edwards Lifesciences Corporation (NYSE:EW) see US$1.5b decrease in market cap last week, although long-term gains have benefitted them.\n• Though their holding amounts to less than 1%, we can see that board members collectively own US$418m worth of shares (at current prices).\n• is currently the largest shareholder, with 12% of shares outstanding.\n• Still, the 12% one-year gains may have helped mitigate their overall losses.\n• And the group that holds the biggest piece of the pie are institutions with 88% ownership.\n• In comparison, the second and third largest shareholders hold about 9.5% and 4.4% of the stock.\n• Our data suggests that insiders own under 1% of Edwards Lifesciences Corporation in their own names.\n• Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/institutional-investors-edwards-lifesciences-corporation-123030109.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>